Learn new technologies to overcome COVID's lasting effects
The COVID-19 pandemic has caused more than 300 million cases globally. Even though most patients fully recover, 10-30% suffer from persistent symptoms that have a devastating effect on their quality of life, known as Long COVID. Join global health research, physician, and head of a Long COVID clinical study, Dr. Shai Efrati, as he reviews the pathophysiology, clinical information and therapeutic approach used to heal Long COVID patients.
Complementary snacks & beverages will be available for attendees.
About Dr. Shai Efrati
Dr. Shai Efrati is a professor at Sackler School of Medicine and the Sagol School of Neuroscience of Tel Aviv University and the director of the Sagol center for hyperbaric medicine and research at Shamir (Assaf-Harofeh) Medical Center in Israel. The center, under Prof. Efrati management, has become one of the largest hyperbaric center worldwide, currently treating more than 200 patients per day. Prof. Efrati is also the director of Research & Development at the Medical center, affiliated to Tel-Aviv University. Taking the two passions/positions together Dr. Efrati has initiated a research program focusing on the neuroplasticity (regeneration of damage brain tissue) by the use of Hyperbaric Oxygen Therapy (HBOT). In the first clinical studies it was demonstrated that HBOT can induce neuroplasticity in post stroke and Traumatic Brain Injury even years after the acute Insult. The important clinical results gained from the research program have led to fruitful ongoing cooperation including multidiscipline team focusing on the regenerative effects of hyperbaric oxygen in age related functional decline and Alzheimer disease.
Discussion
By posting you agree to the Terms and Privacy Policy.